The serotonin 5-HT4 receptor and the amyloid precursor protein processing

被引:51
|
作者
Lezoualc'h, F [1 ]
Robert, SJ
机构
[1] Univ Paris Sud, Inst Signalisat & Innovat Therapeut IFR 75, Fac Pharm, INSERM,U Cardiol Cellulaire & Mol 446, F-92296 Chatenay Malabry, France
[2] Univ Paris Sud, Inst Signalisat & Innovat Therapeut IFR 75, Fac Pharm, UPRES,EAD2707, F-92296 Chatenay Malabry, France
关键词
acetylcholine; Alzheimer's disease; G protein coupled-receptor; serotonin; 5-HT4; receptor; amyloid precursor protein;
D O I
10.1016/S0531-5565(02)00157-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
A large body of evidence supports a major role for the serotonin 5-HT4 receptor in learning and memory and it is suggested that 5-HT4 agonists may be beneficial for memory disorders such as Alzheimer's disease (AD). The 5-HT4 receptors are members of the G protein-coupled receptor superfamily and are positively coupled to adenylyl cyclase. In this communication we show that a neuronal isoform of the human 5-HT4 receptor, h5-HT4(g) regulates the metabolism of the amyloid precursor protein (APP695). This process is observed in Chinese hamster ovary (CHO) cells stably coexpressing the neuronal h5-HT4(g) receptor isoform as well as the human APP695. The 5-HT4 agonists strongly stimulate the release of the non-amyloidogenic soluble amyloid precursor protein sAPPalpha as detected by immunoblot. Prucalopride was more potent than serotonin (5-HT) with regard to enhanced of sAPPalpha secretion. This process was blocked by a selective 5-HT4 antagonist, GR113808. Furthermore, 5-HT4 ligands enhance sAPPalpha secretion via cAMP-dependent and PKA-independent signalling pathways indicating there are alternative pathways by which the h5-HT4 receptor via cAMP regulates APP metabolism. Because the alpha-cleavage event may preclude the formation of amyloidogenic peptides, and secreted sAPPalpha has putative neuroprotective and enhancing-memory properties, our present data suggest the 5-HT4 receptor as a novel target for the treatment of AD. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [21] Distinct functional effects of human 5-HT4 receptor isoforms on β-amyloid secretion
    Robert, Sylvain J.
    Lezoualc'h, Frank
    NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) : 163 - 165
  • [22] SEROTONIN 5-HT3, 5-HT4, AND 5-HT-M RECEPTORS
    HOYER, D
    NEUROPSYCHOPHARMACOLOGY, 1990, 3 (5-6) : 371 - 383
  • [23] Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling
    Pimenova, Anna A.
    Thathiah, Amantha
    De Strooper, Bart
    Tesseur, Ina
    PLOS ONE, 2014, 9 (01):
  • [24] THE 5-HT4 RECEPTOR - A PLACE IN THE SUN
    BOCKAERT, J
    FOZARD, JR
    DUMUIS, A
    CLARKE, DE
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (04) : 141 - 145
  • [25] Selective 5-HT4 receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (02) : 83 - 83
  • [26] THE 5-HT4 RECEPTOR - NAUGHTY, BUT NICE
    CLARKE, DE
    CRAIG, DA
    FOZARD, JR
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (10) : 385 - 386
  • [27] Translating 5-HT4 receptor pharmacology
    Sanger, G. J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (12): : 1235 - 1238
  • [28] Serotonin4 (5-HT4) receptor Agonists are putative antidepressants with a rapid onset of action
    Lucas, Guillaume
    Rymar, Vladimir V.
    Du, Jenny
    Mnie-Filali, Ouissame
    Bisgaard, Christina
    Manta, Stella
    Lambas-Senas, Laura
    Wiborg, Ove
    Haddjeri, Nasser
    Pineyro, Graciela
    Sadikot, Abbas F.
    Debonnel, Guy
    NEURON, 2007, 55 (05) : 712 - 725
  • [29] Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia
    Suzuki, T
    Iwata, N
    Kitamura, Y
    Kitajima, T
    Yamanouchi, Y
    Ikeda, M
    Nishiyama, T
    Kamatani, N
    Ozaki, N
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 121B (01): : 7 - 13
  • [30] Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism
    Lefebvre, H
    Cartier, D
    Duparc, C
    Contesse, V
    Lihrmann, I
    Delarue, C
    Vaudry, H
    Fischmeister, R
    Kuhn, JM
    ENDOCRINE RESEARCH, 2000, 26 (04) : 583 - 587